Simplicity Wealth LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 4,438 shares of the exchange traded fund’s stock, valued at approximately $360,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $29,000. Lee Danner & Bass Inc. purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $38,000. Bank of Jackson Hole Trust purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $43,000. Addison Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF by 27.4% in the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after acquiring an additional 115 shares during the period. Finally, O Shaughnessy Asset Management LLC grew its stake in SPDR S&P Biotech ETF by 38.6% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after acquiring an additional 200 shares in the last quarter.
SPDR S&P Biotech ETF Trading Down 0.0%
SPDR S&P Biotech ETF stock opened at $84.36 on Friday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The firm has a market capitalization of $5.00 billion, a PE ratio of 11.47 and a beta of 0.85. The firm’s 50 day simple moving average is $78.99 and its 200 day simple moving average is $86.40.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Using the MarketBeat Dividend Yield Calculator
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What is the Euro STOXX 50 Index?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.